U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2028120281Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With CancerRecruitingNo Results AvailableCancer|ChemotherapyBehavioral: Nurse support and selfmanagement interventionhttps://ClinicalTrials.gov/show/NCT02298972
2028220282Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid TumorsRecruitingNo Results AvailableAdult Solid Neoplasm|Metastatic Melanoma|Metastatic Renal Cell Cancer|Recurrent Colorectal Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Renal Cell Carcinoma|Stage IV Ovarian Cancer|Stage IVA Colorectal Cancer|Stage IVB Colorectal CancerOther: Laboratory Biomarker Analysis|Biological: Pembrolizumab|Biological: Ziv-Aflibercepthttps://ClinicalTrials.gov/show/NCT02298959
2028320283AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy in People With Metastatic Colorectal CancerRecruitingNo Results AvailableColorectal Cancer|Colorectal Neoplasms|Colorectal CarcinomaDrug: AMP-224|Radiation: Stereotactic Body Radiation Therapy(SBRT)|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT02298946
2028420284Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe ThrombocytopeniaRecruitingNo Results AvailableThrombocytopenia|Alloimmune Platelet RefractorinessDrug: Eculizumabhttps://ClinicalTrials.gov/show/NCT02298933
2028520285AZD0914 Phase 1 ADME Study in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: AZD0914https://ClinicalTrials.gov/show/NCT02298920
2028620286CPET in Colorectal SurgeryCompletedNo Results AvailableColorectal Cancer|Surgeryhttps://ClinicalTrials.gov/show/NCT02298907
2028720287Comparison of LDL Particle Count With Other Available Lipid TestsRecruitingNo Results AvailableHyperlipidemiahttps://ClinicalTrials.gov/show/NCT02298894
2028820288Ocular Surface MicrobiomeRecruitingNo Results AvailableDry Eye Syndromeshttps://ClinicalTrials.gov/show/NCT02298881
2028920289Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot StudyCompletedHas ResultsMuscle Cramps|CirrhosisDrug: Baclofenhttps://ClinicalTrials.gov/show/NCT02298868
2029020290Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.CompletedNo Results AvailableOvarian CancerBehavioral: Individualised follow-uphttps://ClinicalTrials.gov/show/NCT02298855
2029120291In-Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol SolutionWithdrawnNo Results AvailableHealthy VolunteersDevice: Platelets stored in InterSol|Device: Platelets stored in Plasmahttps://ClinicalTrials.gov/show/NCT02298842
2029220292Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies DiseaseEnrolling by invitationNo Results AvailablePeyronie's DiseaseDrug: Subjects Previously Treated with AA4500https://ClinicalTrials.gov/show/NCT02298829
2029320293B-Cell Hematologic Malignancy Vaccination RegistryEnrolling by invitationNo Results AvailableMonoclonal Gammopathy of Undetermined Significance|Multiple Myeloma|Waldenstrom Macroglobulinemia|Lymphocytosis|Lymphoma, Non-Hodgkin|B-Cell Chronic Lymphocytic Leukemia|Hematological Malignancieshttps://ClinicalTrials.gov/show/NCT02298816
2029420294QT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced HypoglycaemiaNot yet recruitingNo Results AvailableDiabetes Related ComplicationsDevice: Holter and Glucose monitoringhttps://ClinicalTrials.gov/show/NCT02298803
2029520295Effect of Dietary Habits on Metabolic HealthRecruitingNo Results AvailableOverweight|Obesity|Prediabetes|MealsBehavioral: Meal schedulehttps://ClinicalTrials.gov/show/NCT02298790
2029620296Metabolomic Analysis of Systemic SclerosisActive, not recruitingNo Results AvailableScleroderma (Limited and Diffuse)|Undifferentiated Connective Tissue Disease|Raynaud Disease|Vascular Disease|Healthy Control SubjectsProcedure: - Skin biopsy - Urine sample - Blood samplehttps://ClinicalTrials.gov/show/NCT02298777
2029720297Back Pain and PostTraumaticStressDisorder. A Randomized Clinical TrialRecruitingNo Results AvailableLow Back Pain|PTSDOther: Standard back pain treatment|Other: Standard back pain treatment + 10 psychotherapeutic sessionshttps://ClinicalTrials.gov/show/NCT02298764
2029820298Exposure Therapy as Aftercare for Alcohol Use DisorderRecruitingNo Results AvailableAlcohol Use DisordersBehavioral: Cue Exposure Treatmenthttps://ClinicalTrials.gov/show/NCT02298751
2029920299Effect of Vit D on New-onset AF in HypertensionCompletedNo Results AvailableAtrial Fibrillation|Hypertensionhttps://ClinicalTrials.gov/show/NCT02298738
2030020300Individual Metabolism and Physiology Signature StudyRecruitingNo Results AvailableInsulin Resistance|Metabolic Syndrome X|ObesityOther: DGA Diet Plan|Other: NHANES Diet Planhttps://ClinicalTrials.gov/show/NCT02298725
2030120301Biomarker for Hurler DiseaseRecruitingNo Results AvailableMucopolysaccharidosis Type I|MPS I|Hurler-Scheie Syndrome|Gargoylism, Hurler Syndromehttps://ClinicalTrials.gov/show/NCT02298712
2030220302Biomarker for Sly DiseaseRecruitingNo Results AvailableMucopolysaccharidosis VII|Sly Disease|Beta-Glucuronidase Deficiency|GUSB Deficiencyhttps://ClinicalTrials.gov/show/NCT02298699
2030320303Biomarker for Sanfilippo DiseaseRecruitingNo Results AvailableMucopolysaccharidosis Type 3 A|Mucopolysaccharidosis Type 3 B|Mucopolysaccharidosis Type 3 C|Mucopolysaccharidosis Type 3 D|Heparan Sulfate Sulfatase Deficiencyhttps://ClinicalTrials.gov/show/NCT02298686
2030420304Biomarker for Mucolipidosis Disorder Type I, II, III or IVRecruitingNo Results AvailableMucolipidosis Type I|Mucolipidosis Type II|Mucolipidosis Type III|Mucolipidosis Type IV|Mucolipidosishttps://ClinicalTrials.gov/show/NCT02298673
2030520305Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCIRecruitingNo Results AvailableAutonomic DysreflexiaDrug: BOTOXhttps://ClinicalTrials.gov/show/NCT02298660
2030620306Biomarker for GM1/GM2 - GangliosidosesRecruitingNo Results AvailableGangliosidosis|GM1-Gangliosidosis|GM2-Gangliosidosis|Hexosaminidase Activator Deficiency|Tay-Sachs Disease, AB Variant|Hexosaminidase A and B Deficiency|Sandhoff Diseasehttps://ClinicalTrials.gov/show/NCT02298647
2030720307Biomarker for Farber DiseaseRecruitingNo Results AvailableFarber's Lipogranulomatosis|Ceramidase Deficiency|Farber Disease|Acid Ceramidase Deficiency|AC Deficiencyhttps://ClinicalTrials.gov/show/NCT02298634
2030820308Pomegranate Juice and Metabolic SyndromeCompletedNo Results AvailableMetabolic SyndromeOther: pomegranate juice|Other: placebohttps://ClinicalTrials.gov/show/NCT02298621
2030920309Efficacy and Safety of IRE for RMsRecruitingNo Results AvailableKidney CancerDevice: Nano Knifehttps://ClinicalTrials.gov/show/NCT02298608
2031020310Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell CarcinomaNot yet recruitingNo Results AvailableCarcinoma, Squamous|Squamous Cell Carcinoma|Oropharyngeal Neoplasms|Oropharyngeal CancerDrug: cisplatin|Drug: Cetuximab|Drug: BYL719https://ClinicalTrials.gov/show/NCT02298595

* Görseller ve İçerik tekif hakkına sahip olabilir